101 related articles for article (PubMed ID: 2902671)
1. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
Robuschi M; Simone P; Vaghi A; Ventresca GP; Bianco S
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):101-4. PubMed ID: 2881897
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the bronchodilator effects of broxaterol and salbutamol.
Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
[TBL] [Abstract][Full Text] [Related]
4. Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
Perruchoud AP; Bründler H; Godly R; Imhof E; Herzog H
Respiration; 1987; 51(2):113-8. PubMed ID: 2884706
[TBL] [Abstract][Full Text] [Related]
5. Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
Löfdahl CG; Sigvaldasson A; Skoogh BE; Svedmyr N
Respiration; 1989; 55 Suppl 2():15-9. PubMed ID: 2572036
[TBL] [Abstract][Full Text] [Related]
6. Broxaterol: therapeutic trials and safety profile.
Ziment I
Respiration; 1989; 55 Suppl 2():28-40. PubMed ID: 2572038
[TBL] [Abstract][Full Text] [Related]
7. Role of broxaterol in bronchial hyperresponsiveness.
Bianco S
Respiration; 1989; 55 Suppl 2():20-7. PubMed ID: 2572037
[TBL] [Abstract][Full Text] [Related]
8. Dose-response comparison of broxaterol and salbutamol pressurized aerosols.
Simone P; Borgia M; Torre L; Ventresca GP
Eur J Clin Pharmacol; 1990; 39(6):565-8. PubMed ID: 1982761
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of a new beta 2-agonist (broxaterol) on bronchospasm induced by methacholine (blind study versus salbutamol)].
Corrias A; Corona GB; Pelosi U; Corda R
Pediatr Med Chir; 1989; 11(1):61-3. PubMed ID: 2566160
[TBL] [Abstract][Full Text] [Related]
10. Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
Rampulla C; Corsico R; Majani U; Lodola E
Respiration; 1985; 47(4):299-302. PubMed ID: 2861630
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the bronchodilating activity and the tolerability of broxaterol administered as a solution by inhalation.
Ferrari M; Olivieri M; Biasin C; Pisati R; Lodola E; Lo Cascio V
Arzneimittelforschung; 1993 May; 43(5):553-8. PubMed ID: 8101082
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.
Petraglia A; Gurrieri G; Scarpitta M; Pisati R; Ansalone D
Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):365-70. PubMed ID: 1359998
[TBL] [Abstract][Full Text] [Related]
13. Bronchodilating activity of broxaterol transdermal patch and its protective effect on bronchial constriction induced by inhaled distilled water mist.
Robuschi M; Gambaro G; Spagnotto S; Scuri M; Fai V; Lodola E; Pisati R; Bianco S
Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):407-11. PubMed ID: 1684178
[TBL] [Abstract][Full Text] [Related]
14. Broxaterol: pharmacological profile of a unique structural feature.
Della Bella D
Respiration; 1989; 55 Suppl 2():10-4. PubMed ID: 2572035
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the bronchodilating effects of five beta-adrenergic stimulants administered by inhalation to patients with bronchial asthma].
Kokubu H
Arerugi; 1993 Jun; 42(6):699-705. PubMed ID: 8102230
[TBL] [Abstract][Full Text] [Related]
16. Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol.
Petraglia A; Scarpitta M; Ansalone D; Gurrieri G; Galzerano V; Calvanese RC; Federico S; Zinno A
Int J Clin Pharmacol Res; 1990; 10(5):299-304. PubMed ID: 1981879
[TBL] [Abstract][Full Text] [Related]
17. Acute ventilatory and gas-exchange effects of a new beta-2 agonist, broxaterol, in asthmatics.
Tantucci C; Burni B; Dottorini ML; Malerba M; Peccini F; Gurrieri G; Sorbini CA; Grassi V
Int J Clin Pharmacol Res; 1990; 10(3):183-9. PubMed ID: 1977709
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthma.
Siegel SC; Katz RM; Rachelefsky GS; Brandon ML; Borgen LA
J Allergy Clin Immunol; 1985 Jun; 75(6):698-705. PubMed ID: 2861219
[TBL] [Abstract][Full Text] [Related]
19. Broxaterol: a new beta2-adrenoceptor agonist for the treatment of reversible airways disease. Proceedings of the satellite symposium. Budapest, September 8, 1988.
Respiration; 1989; 55 Suppl 2():1-44. PubMed ID: 2572034
[No Abstract] [Full Text] [Related]
20. [Efficacy of broxaterol (vs salbutamol) in asthma induced by physical exercise in children].
Corrias A; Pelosi U; Corona GB; Minelli R; Peri M; Corda R
Pediatr Med Chir; 1989; 11(2):161-3. PubMed ID: 2569730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
